New Jersey's Home Grow Ban Drives Medical Patients Away as Recreational Market Takes Over

New Jersey’s medical cannabis scene is looking a bit thin lately. Since the recreational market fired up in 2022, patient registrations have plummeted from a peak of nearly 130,000 to just under 52,000 as of late 2025. Even with the state slashing card fees to a mere ten bucks and highlighting perks like tax-free shopping and priority lines, thousands are still letting their medical status lapse. Many advocates point to one massive missing piece: the right to grow at home. While most legal states allow patients to tend their own gardens, the Garden State remains one of the few holdouts where home cultivation is strictly off-limits.

This trend is a big deal for the community because it shows that lower costs alone aren't enough to sustain a medical program when adult-use access is so easy. For everyday enthusiasts, it highlights the ongoing battle for true cannabis freedom. If Jersey wants to keep its medical program thriving, they’ll likely need to listen to the patients calling for the right to cultivate their own medicine.